TC Biopharm (Holdings) Plc (TCBP)
NASDAQ: TCBP · IEX Real-Time Price · USD
1.530
-0.040 (-2.55%)
At close: Apr 26, 2024, 4:00 PM
1.570
+0.040 (2.61%)
After-hours: Apr 26, 2024, 7:36 PM EDT
TC Biopharm (Holdings) Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
1.57M USD
Revenue Chart
* The company reports in GBP currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 4.63M | 1.99M | 75.57% |
Dec 31, 2021 | 2.64M | -72.28K | -2.67% |
Dec 31, 2020 | 2.71M | -1.80M | -39.89% |
Dec 31, 2019 | 4.51M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTCBP News
- 23 days ago - TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies - PRNewsWire
- 25 days ago - TCBP Increasing Treatment Capacity with Expanded Manufacturing Process - PRNewsWire
- 5 weeks ago - TCBP Adjourns General Meeting Until a Later Date - PRNewsWire
- 5 weeks ago - TCBP Announces Exercise of Series D Warrants For Cash - PRNewsWire
- 2 months ago - Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show" - PRNewsWire
- 2 months ago - TCBP Announces Shareholder Update Call on March 5th 2024 - PRNewsWire
- 2 months ago - TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial - PRNewsWire
- 2 months ago - TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe - PRNewsWire